Carnitine: Clinical Trials

29 trials of Carnitine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 9 unknown, 2 active not recruiting, 2 terminated. 29 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 329Completed 14, Unknown 9, Active not recruiting 2, Terminated 2, Suspended 1, Withdrawn 1
Phase 29Completed 5, Unknown 3, Terminated 1

Follow Carnitine: new trials by email Literature Review of Carnitine trials Research Report on Carnitine

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men
L-carnitine - Oligoasthenozoospermia, Male Infertility
Phase 3Active not recruitingSouth Valley University502026-01-012026-02-11
Comparative Evaluation of the Efficacy of Letrozole, L-Carnitine, and Their Combination on Sperm Quality, Oxidative Stress, and ART Outcomes in Men With Idiopathic Oligoasthenoteratozoospermia.
Letrozole 2.5mg, L-carnitine - Idiopathic Oligoasthenoteratozoospermia, Male Infertility
Phase 2 / Phase 3CompletedTehran University of Medical Sciences902023-12-012026-06-30
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Biospecimen Collection, Calaspargase Pegol, Levocarnitine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 3Active not recruitingChildren's Oncology Group4402023-08-242026-08-21
Evaluation of the Impact of L- Carnitine in Intradialytic Hypotension in Pediatric Patients on Regular Hemodialysis
L Carnitine - Intradialytic Hypotension
Phase 3UnknownAin Shams University502023-05-302023-06-15
L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis
L-carnitine - Rheumatoid Arthritis
Phase 3UnknownTanta University462023-03-052023-03-31
Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
L-Carnitine 500Mg thrice daily, 1g L-Carnitine IV three times a week - Hemodialysis Complication
Phase 2 / Phase 3CompletedBahria University832023-01-012024-08-09
The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma
Placebo, L-Carnitine 500Mg Oral Tablet, Biotin Capsules - Moderate Persistent Asthma
Phase 3UnknownTanta University662022-08-082022-11-30
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg, Atorvastatin 10mg - Dyslipidemias, Cardiovascular Risk Factor
Phase 3UnknownLaboratorios Grossman, S.A.1202018-05-282019-02-26
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
L-carnitine, Placebo - Gastrointestinal Stromal Tumors (GISTs)
Phase 3CompletedAsan Medical Center42018-03-012020-07-13
L-carnitine for Fatigue in COPD
L-carnitine 1000 mg twice daily, Weekly health coaching calls, Placebo capsules - Copd, Fatigue
Phase 2 / Phase 3CompletedMayo Clinic332017-01-012019-01-23
Impact on Functional Status in Older Adults Treated With L-Carnitine
L Carnitine, Supervised exercise, Placebos - Carnitine; Muscle, Functional Status
Phase 2 / Phase 3UnknownHospital de Clínicas Dr. Manuel Quintela602017-01-012017-06-08
L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients
L-carnitine, usual intake - Ammonia Metabolism
Phase 2 / Phase 3UnknownKochi University802016-04-012017-01-16
Carnitine Supplementation and Skeletal Muscle Function
carnitine, placebo - Sarcopenia
Phase 3CompletedGdansk University of Physical Education and Sport282016-02-012019-05-23
Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration
Hydration strategy using saline, Hydration strategy using sodium bicarbonate, L-carnitine - Acute Kidney Injury, Renal Insufficiency
Phase 3TerminatedCentre Hospitalier Universitaire de Nīmes92014-12-012016-03-22
An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne
Adapalene gel with Eucerin, Adapalene gel, Adapalene gel with placebo moisturizer - Acne
Phase 3CompletedMahidol University1202014-07-012017-01-23
L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis
L-carnitine - Acute Pyelonephritis(APN)
Phase 3UnknownShahid Beheshti University782013-11-012013-12-11
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
Valproate, Levocarnitine, Placebo - Spinal Muscular Atrophy
Phase 3UnknownAll India Institute of Medical Sciences602013-08-012016-01-01
The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome
Coenzyme Q10U, L-carnitine - Myelodysplastic Syndrome
Phase 2 / Phase 3UnknownKaplan Medical Center402013-05-012014-01-22
Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants
L-carnitine, 5% Dextrose - Prematurity, Neurodevelopmental Disorder
Phase 2 / Phase 3CompletedMontefiore Medical Center1442013-01-012023-03-08
The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure
Levocarnitine Injection, Levocarnitine placebo - Heart Failure,
Phase 2 / Phase 3CompletedLee's Pharmaceutical Limited2682011-01-012012-04-27

Showing 20 of 29. Sign in to see all of them.

Conditions studied

Fatigue (3)  ·  HIV Infections (2)  ·  Heart Failure (2)  ·  Infertility, Male (2)  ·  Systemic carnitine deficiency (2)  ·  Acne Vulgaris (1)  ·  Acute Kidney Injury (1)  ·  Anemia (1)  ·  Arthritis, Rheumatoid (1)  ·  Atrial Fibrillation (1)  ·  Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Cytomegalovirus Infections (1)  ·  Depression (1)  ·  Dyslipidemias (1)

Sponsors

Tanta University (2)  ·  Ain Shams University (1)  ·  All India Institute of Medical Sciences (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Attikon Hospital (1)  ·  Bahria University (1)  ·  Biolab Sanus Farmaceutica (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Children's Oncology Group (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Gdansk University of Physical Education and Sport (1)  ·  Hospital de Clínicas Dr. Manuel Quintela (1)  ·  Kaplan Medical Center (1)  ·  Kochi University (1)

Countries

United States (6)  ·  Egypt (4)  ·  France (3)  ·  Canada (2)  ·  Iran (2)  ·  Brazil (1)  ·  China (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)  ·  Japan (1)  ·  Mexico (1)  ·  Pakistan (1)  ·  Poland (1)

Top investigators

Acary Souza Bulle Oliveira, MD, PhD (1)  ·  Alaleh Gheisari (1)  ·  Aldo Sgaravatti, MD (1)  ·  Aurelio Cruz Valdez, PhD (1)  ·  Azadeh Eshraghi, Clinical Pharmacist (1)  ·  Azim Hedayatpour, Professor, PhD (1)  ·  Benjamin JW Chow, MD, FRCPC (1)  ·  Brosgart C (1)  ·  Eisa Mohammed Hegazy (1)  ·  Etan Orgel (1)  ·  Fisher E (1)  ·  George Wells, M.Sc., PhD (1)  ·  Golnaz Vaseghi, Ph.D pharmacology (1)  ·  Gulati Sheffali, MD (1)

Results publications

PMID 10190267, PMID 10650325, PMID 10859281, PMID 10919968, PMID 11277825, PMID 11326085, PMID 11529691, PMID 11729302, PMID 11834528, PMID 11895451, PMID 11975885, PMID 12213433, PMID 12417828, PMID 12421890, PMID 12430089, PMID 12485966, PMID 12686036, PMID 12730697, PMID 12829554, PMID 12867219, PMID 12908852, PMID 12972104, PMID 14607021, PMID 14666956, PMID 15007110, PMID 15331429, PMID 15478042, PMID 15553600, PMID 15591005, PMID 15755765, PMID 15849374, PMID 15855667, PMID 16003294, PMID 16034009, PMID 16377285, PMID 16384561, PMID 16461820, PMID 16554528, PMID 16832163, PMID 16891287, PMID 16903986, PMID 16907655, PMID 17039901, PMID 17047160, PMID 17201631, PMID 17559928, PMID 17569881, PMID 17641743, PMID 17910522, PMID 18246928

NIH funding

2009 (1), U10CA023318 (1), U24CA196173 (1), UG1CA189955 (1)